Itoh, K <br/><br/>
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study Group.  [electronic resource] 

 -  Leukemia & lymphoma  Aug 2000 
 - 521-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428190009059271  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lenograstim<br/>Lymphoma, Non-Hodgkin--pathology<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Transplantation, Autologous<br/>Vincristine--administration & dosage